Injecting BRAVELLE®

At Ferring, we understand that having to mix and administer your own medication may seem overwhelming, and increased stress and anxiety levels can potentially hinder your treatment. We want to make it as easy and stress-free as possible.

In a survey among members of RESOLVE, The National Infertility Association, patients who were prescribed multiple injection methods (needle and syringe plus pen) experienced higher levels of anxiety when handling, preparing, and injecting their medications as well as injecting more than one dose a day.1

When you use Ferring fertility products, injection via needle and syringe is the only method you need to learn so you can feel much more confident and relaxed as treatment proceeds. And be sure to ask your doctor about mixing BRAVELLE® with Ferring hMG in 1 syringe to administer 1 injection a day1.

BRAVELLE® is approved for is approved for reconstitution with the Q•Cap™ needle-free vial adapter and both subcutaneous (SC) and intramuscular (IM) injection. Whether your doctor has prescribed an SC or IM injection method, we’ve developed easy-to-follow injection guides. Simply access the instructions below that match your doctor’s recommendation.

Subcutaneous Administration

Step-by-Step Guide

View each step of the injection process, so that you can proceed at your own pace. Or, print out the entire guide and take it with you.

Q•CAP reconstitution:
English Spanish Arabic Chinese Vietnamese

Needle reconstitution:
English Spanish

View the Administration Guide Video
 


Intramuscular Administration

Step-by-Step Guide

View each step of the injection process, so that you can proceed at your own pace. Or, print out the entire guide and take it with you.

Q•CAP reconstitution:
English Spanish

Needle reconstitution:
English Spanish

View the Administration Guide Video
 

If you have any questions or concerns regarding your injections, don't hesitate to contact your health care provider.

Reference: 1. Patient Assessment of Infertility Treatment Administration. Results of An Online Patient Survey. Bethesda, Md: RESOLVE: The National Fertility Association; 2006. 2. Keye WR Jr, Marrs RP, Check JH, et al, for the EMBRACE Study Group. Evaluation of mixed protocols with BRAVELLE (human-derived FSH) and REPRONEX (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization. Fertil Steril. 2004;82:348-357.


Previous:
BRAVELLE®
Next:
BRAVELLE® FAQs